WuXi AppTec Co

WuXi AppTec Co EBIT

The EBIT of WuXi AppTec Co (603259.SS) as of Nov 7, 2026 is 17.00 B CNY. In the previous year, EBIT was 9.91 B CNY — a change of 71.58% (higher).

EBIT

17.00 BCNY

YoY

71.58%

Last updated:

In 2025, WuXi AppTec Co's EBIT was 17.00 B CNY, a 71.58% increase from the 9.91 B CNY EBIT recorded in the previous year.

The WuXi AppTec Co EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2024
9.91 B CNY
Jan 1, 2025
17.00 B CNY
Jan 1, 2026 (e)
30.22 B CNY
Jan 1, 2027 (e)
35.64 B CNY
Jan 1, 2028 (e)
40.97 B CNY
Jan 1, 2029 (e)
44.02 B CNY
Jan 1, 2030 (e)
50.84 B CNY
Jan 1, 2031 (e)
0.00 CNY
The WuXi AppTec Co EBIT history
YEAREBITYoY
est0.00CNY-100.00%
est50.84 BCNY+15.50%
est44.02 BCNY+7.43%
est40.97 BCNY+14.94%
est35.64 BCNY+17.96%
est30.22 BCNY+77.69%
17.00 BCNY+71.58%
9.91 BCNY-2.46%
10.16 BCNY-4.62%
10.65 BCNY+76.43%
6.04 BCNY+78.13%
3.39 BCNY+44.79%
2.34 BCNY-9.43%
2.58 BCNY+57.49%
1.64 BCNY+37.12%
1.20 BCNY+55.10%
771.68 MCNY-10.47%
861.96 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

WuXi AppTec Co Revenue

WuXi AppTec Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2024
33.58 B CNY
9.91 B CNY
8.09 B CNY
Jan 1, 2025
45.46 B CNY
17.00 B CNY
19.15 B CNY
Jan 1, 2026 (e)
61.22 B CNY
30.22 B CNY
23.38 B CNY
Jan 1, 2027 (e)
75.34 B CNY
35.64 B CNY
27.49 B CNY
Jan 1, 2028 (e)
88.50 B CNY
40.97 B CNY
32.13 B CNY
Jan 1, 2029 (e)
100.64 B CNY
44.02 B CNY
35.77 B CNY
Jan 1, 2030 (e)
116.64 B CNY
50.84 B CNY
41.35 B CNY
Jan 1, 2031 (e)
93.31 B CNY
0.00 CNY
0.00 CNY

WuXi AppTec Co Margins

WuXi AppTec Co stock margins

The WuXi AppTec Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of WuXi AppTec Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for WuXi AppTec Co.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2024
41.48 %
29.51 %
24.08 %
Jan 1, 2025
47.64 %
37.41 %
42.13 %
Jan 1, 2026 (e)
47.64 %
49.36 %
38.19 %
Jan 1, 2027 (e)
47.64 %
47.31 %
36.50 %
Jan 1, 2028 (e)
47.64 %
46.29 %
36.31 %
Jan 1, 2029 (e)
47.64 %
43.74 %
35.54 %
Jan 1, 2030 (e)
47.64 %
43.59 %
35.45 %
Jan 1, 2031 (e)
47.64 %
0.00 %
0.00 %

WuXi AppTec Co Stock analysis

What does WuXi AppTec Co do? WuXi AppTec Co Ltd is a Chinese company that was founded in 2000 and specializes in the development of customer-oriented services in the pharmaceutical research and in vitro diagnostics sectors. The company operates multiple facilities in China, the USA, Europe, and Singapore. The business model of WuXi AppTec is based on the development and provision of services to meet the needs of customers worldwide. This includes activities such as bioanalysis, chemical development, drug manufacturing, and regulatory compliance and quality assurance services. In terms of various industries, the company is divided into three main divisions. The Chemical Division specializes in chemical development and drug manufacturing. The team has expertise in synthesizing complex molecules, scaling up for clinical trials, manufacturing bulk products for commercial use, and supplying APIs for formulation. The company has state-of-the-art facilities and technologies to ensure high product quality and fast production time. The Medical Device Division provides in vitro diagnostics for the global market to enable rapid and reliable medical diagnosis. The focus is on developing innovative technologies and applications in the fields of oncology, infectious diseases, and neurology. The company has many partnerships with leading in vitro diagnostics companies to enhance the quality and reach of products and services. The Biological Division specializes in the development of biopharmaceutical products and services. This includes the development of monoclonal antibodies to the production of recombinant proteins. The services include process development, manufacturing, characterization, and analysis of biological products. WuXi AppTec is at the forefront of technology and provides its customers with state-of-the-art facilities and technologies. In addition to the aforementioned services, WuXi AppTec also offers solutions in the field of bioanalytics, supporting the development of analytical methods and drug validation. The company has also recently expanded into other areas, including the acquisition of NextCODE Health, a firm specializing in genetic diagnostics and analysis tools. The company operates internationally and collaborates with a wide range of customers in the pharmaceutical and biotech sectors. It is also part of a global network of companies focusing on therapeutic technologies, clinical trials, drug marketing, and other aspects of the pharmaceutical industry. WuXi AppTec aims to provide its customers with high-quality products and services that are scientifically sound and effective. The company invests in research and development to provide its customers with the latest technologies and discoveries. WuXi AppTec Co is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing WuXi AppTec Co's EBIT

WuXi AppTec Co's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of WuXi AppTec Co's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

WuXi AppTec Co's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in WuXi AppTec Co’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about WuXi AppTec Co stock

EBIT of WuXi AppTec Co is 17.00 B CNY in 2025.

EBIT of WuXi AppTec Co changed from 9.91 B CNY to 17.00 B CNY, representing a 71.58% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT WuXi AppTec Co since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's WuXi AppTec Co historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — WuXi AppTec Co

All Key Metrics — WuXi AppTec Co